Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 16/20 | 0.51 |
| ▸ | GPR34 | Q9UPC5 | 8/20 | 0.51 |
| ▸ | GPR174 | Q9BXC1 | 6/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13745776 | 0.86 | P2RY10 (0.49) | P2RY10GPR34GPR174 | |
| SCHEMBL28350789 | 0.84 | P2RY10 (0.55) | P2RY10GPR34GPR174 | |
| SCHEMBL15127112 | 0.84 | P2RY10 (0.49) | P2RY10GPR34GPR174 | |
| SCHEMBL2474832 | 0.84 | LAP3 (0.36) | P2RY10GPR34GPR174 | |
| SCHEMBL13745777 | 0.80 | P2RY10 (0.48) | P2RY10GPR34GPR174 | |
| SCHEMBL21067424 | 0.79 | P2RY10 (0.47) | P2RY10GPR34GPR174 | |
| SCHEMBL1331868 | 0.79 | P2RY10 (0.53) | P2RY10GPR34GPR174 | |
| SCHEMBL9910884 | 0.79 | P2RY10 (0.49) | P2RY10GPR34GPR174 | |
| SCHEMBL13745796 | 0.79 | P2RY10 (0.50) | P2RY10GPR34GPR174 | |
| SCHEMBL13745781 | 0.79 | P2RY10 (0.71) | P2RY10GPR34GPR174 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120116104-A1 | MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES | CHEN SU (US) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120116104-A1 | MIXTURES OF AND METHODS OF USE FOR POLYUNSATURATED FATTY ACID-CONTAINING PHOSPHOLIPIDS AND ALKYL ETHER PHOSPHOLIPIDS SPECIES | PHOSPHO1, SGMS1, SGMS2 | P2RY10 778/4885GPR34 1612/4885GPR174 1885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.